Kimi Iguchi's most recent trade in Sage Therapeutics Inc was a trade of 13,500 Common Stock done . Disclosure was reported to the exchange on Aug. 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 13,500 | 85,041 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.96 per share. | 05 Aug 2024 | 3,636 | 81,405 (0%) | 0% | 9.0 | 32,579 | Common Stock |
| Sage Therapeutics Inc | Iguchi Kimi | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 11,250 | 81,679 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 02 Jan 2024 | 1,642 | 70,429 (0%) | 0% | 1.4 | 2,233 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 1,642 | 0 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 3,000 | 1,642 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 15 Mar 2023 | 3,000 | 65,560 (0%) | 0% | 1.4 | 4,080 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 21 Feb 2023 | 750 | 62,310 (0%) | 0% | 1.4 | 1,020 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 750 | 4,892 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 250 | 4,642 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 21 Feb 2023 | 250 | 62,560 (0%) | 0% | 1.4 | 340 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 16,720 | 16,720 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 2,850 | 62,474 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.16 per share. | 03 Feb 2023 | 914 | 61,560 (0%) | 0% | 44.2 | 40,362 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 1,600 | 5,642 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 09 Jan 2023 | 1,600 | 59,624 (0%) | 0% | 1.4 | 2,176 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 1,800 | 7,242 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 04 Jan 2023 | 1,800 | 58,024 (0%) | 0% | 1.4 | 2,448 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 17 Feb 2022 | 4,500 | 55,600 (0%) | 0% | 1.4 | 6,120 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 4,500 | 9,042 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 15,200 | 15,200 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2021 | 2,500 | 495 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 22 Nov 2021 | 2,500 | 50,100 (0%) | 0% | 1.4 | 3,400 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 22 Nov 2021 | 1,000 | 51,100 (0%) | 0% | 1.4 | 1,360 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2021 | 505 | 13,542 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2021 | 495 | 0 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2021 | 3,800 | 48,624 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.29 per share. | 19 Oct 2021 | 1,024 | 47,600 (0%) | 0% | 40.3 | 41,257 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 3,500 | 43,355 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 3,000 | 16,047 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 15 Jun 2021 | 3,000 | 39,855 (0%) | 0% | 1.4 | 4,080 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 15 Jun 2021 | 2,000 | 44,533 (0%) | 0% | 1.4 | 2,720 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 2,000 | 14,047 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.80 per share. | 15 Jun 2021 | 822 | 42,533 (0%) | 0% | 58.8 | 48,334 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 13 Apr 2021 | 1,500 | 36,855 (0%) | 0% | 1.4 | 2,040 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 948 | 0 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 552 | 2,995 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. | 05 Jan 2021 | 1,750 | 35,355 (0%) | 0% | 1.4 | 2,380 | Common Stock |
| Sage Therapeutics Inc | Kimi Iguchi | CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2021 | 1,750 | 948 | - | - | Stock Option (Right to Buy) |